Ryusuke Omiya
Chugai Pharmaceutical Co., Ltd. (Japan) · 18 works · 798 citations · h-index 13
Top works
- B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance
- Interleukin 15 promotes antigen-independent in vitro expansion and long-term survival of antitumor cytotoxic T lymphocytes.
- Inhibition of EBV-Induced Lymphoproliferation by CD4+ T Cells Specific for an MHC Class II Promiscuous Epitope
- Identification of an antigenic epitope for helper T lymphocytes from carcinoembryonic antigen.
- Single-cell multi-omics analysis identifies two distinct phenotypes of newly-onset microscopic polyangiitis
- Recognition of Prostate and Breast Tumor Cells by Helper T Lymphocytes Specific for a Prostate and Breast Tumor-Associated Antigen, TARP
- Identification of naturally processed helper T-cell epitopes from prostate-specific membrane antigen using peptide-based in vitro stimulation.
- Genome-wide CRISPR screen in human T cells reveals regulators of FOXP3
- Structure of the Plexin Ectodomain Bound by Semaphorin-Mimicking Antibodies
- Leucocyte‐associated immunoglobulin‐like receptor‐1 is an inhibitory regulator of contact hypersensitivity
- Recognition of Adult T-Cell Leukemia/Lymphoma Cells by CD4+ Helper T Lymphocytes Specific for Human T-Cell Leukemia Virus Type I Envelope Protein
- Single-cell analysis reveals immune cell abnormalities underlying the clinical heterogeneity of patients with systemic sclerosis
- Neutrophil single-cell analysis identifies a type II interferon-related subset for predicting relapse of autoimmune small vessel vasculitis
- T-cell help is a limiting factor for rare anti-influenza memory B cells to re-enter germinal centers and generate potent broadly neutralizing antibodies
- Epitope specificity shapes the CD4+ T-cell response to influenza virus infection in mice
- Author Correction: Genome-wide CRISPR screen in human T cells reveals regulators of FOXP3
- Design and Optimization of Peptide-Based Vaccines for Cancer
- A promising synthetic peptide for the design of an Epstein-Barr virus vaccine